Life Sciences

Can Shazam’s Ex-CFO Help TrialReach Tune In To Patients?

trialreach

 

Life Sciences - How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process
How Artificial Intelligence Can Enhance the Clinical Data Review and Cleaning Process

This guide analyzes how artificial intelligence – including machine learning – can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.

Get the Guide

Keith Lovell just left Shazam, the company behind the popular app that magically tells you the artist performing the song playing in the background at Cheesecake Factory. With almost a decade as the company’s CFO, he chose to join TrialReach, a technology company focused on helping patients find the clinical trials they’re eligible for, based on a series of questions. The company is currently focused on diabetes trials, but will expand to other medical conditions with time. 

keith-lovell-trial-reach

Keith Lovell, Courtesy of LondonlovesBusiness.com

The life sciences industry has long needed new blood to help companies meet the digital expectations of today’s patients and consumers. With Lovell on the team, the future looks bright for TrialReach, continuing on its path to improving subject recruitment and, ultimately, public health.

About the Author

Sr. Marketing Manager, Industries, Perficient

More from this Author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe to the Weekly Blog Digest:

Sign Up